Your browser doesn't support javascript.
loading
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Fransson, Per; Nilsson, Per; Gunnlaugsson, Adalsteinn; Beckman, Lars; Tavelin, Björn; Norman, David; Thellenberg-Karlsson, Camilla; Hoyer, Morten; Lagerlund, Magnus; Kindblom, Jon; Ginman, Claes; Johansson, Bengt; Björnlinger, Kirsten; Seke, Mihajl; Agrup, Måns; Zackrisson, Björn; Kjellén, Elisabeth; Franzén, Lars; Widmark, Anders.
Afiliação
  • Fransson P; Department of Nursing, Umeå University, Umeå, Sweden. Electronic address: per.m.fransson@umu.se.
  • Nilsson P; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.
  • Gunnlaugsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.
  • Beckman L; Department of Oncology, Sundsvall Hospital, Sundsvall, Sweden.
  • Tavelin B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Norman D; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Thellenberg-Karlsson C; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Hoyer M; Department of Oncology and Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Lagerlund M; Department of Oncology, Kalmar Hospital, Kalmar, Sweden.
  • Kindblom J; Department of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Ginman C; Department of Oncology, Karlstad Central Hospital, Karlstad, Sweden.
  • Johansson B; Department of Oncology, Örebro University Hospital, Örebro University, Örebro, Sweden.
  • Björnlinger K; Department of Oncology, Ryhov Hospital, Jönköping, Sweden.
  • Seke M; Department of Oncology, Centrallasarettet, Växjö, Sweden.
  • Agrup M; Department of Oncology, Linköping University Hospital, Linköping, Sweden.
  • Zackrisson B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Kjellén E; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Lund, Sweden.
  • Franzén L; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
  • Widmark A; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Lancet Oncol ; 22(2): 235-245, 2021 02.
Article em En | MEDLINE | ID: mdl-33444529
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fracionamento da Dose de Radiação / Radioterapia de Intensidade Modulada / Hipofracionamento da Dose de Radiação País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fracionamento da Dose de Radiação / Radioterapia de Intensidade Modulada / Hipofracionamento da Dose de Radiação País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article